Target intelligence / Profile preview

Wiskott-Aldrich syndrome-like protein mRNA 3' untranslated region (WASL mRNA 3'UTR)

Target
WASL mRNA 3'UTR
Molecular classification
RNA, Messenger RNA, Untranslated region
01

Overview

The Wiskott-Aldrich syndrome-like protein (WASL) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the WASL transcript, which encodes the N-WASP protein (UniProt P46108). N-WASP is a key scaffold protein that activates the Arp2/3 complex, driving branched actin polymerization essential for cell motility, endocytosis, and the formation of invasive structures like invadopodia (NCBI Gene ID: 8976). The 3'UTR serves as a hub for post-transcriptional regulation, containing multiple binding sites for tumor-suppressive microRNAs, such as miR-145 and miR-218, which repress WASL expression (PubMed: 23103957, 25103498). In many aggressive cancers, the loss of these regulatory microRNAs leads to the pathological overexpression of WASL, significantly increasing the metastatic potential of tumor cells. Consequently, the WASL mRNA 3'UTR is an attractive target for RNA-based therapeutics, including microRNA mimics and antisense oligonucleotides, aimed at restoring translational repression and inhibiting cancer cell invasion.

Other names
N-WASP mRNA 3'UTRWASL 3' untranslated regionWiskott-Aldrich syndrome-like 3'UTR
02

Mechanism of action

MicroRNA-mediated gene silencing and translational repression

03

Biological functions

Regulation of actin cytoskeleton organizationCell migrationPost-transcriptional gene regulationmRNA stability regulation
04

Disease associations

Cancer metastasisBreast cancerProstate cancerColorectal cancer
05

Safety considerations

Off-target effects on other mRNA transcriptsSystemic delivery challenges to target tissuesPotential disruption of normal actin-dependent processes in healthy cells
06

Interacting drugs

miR-145 mimics (experimental)

2 more in the full profile.

07

Biomarkers

WASL mRNA expression levelsN-WASP protein levelsmiR-145 expression levelsmiR-218 expression levels

Beyond the preview

Go deeper on Wiskott-Aldrich syndrome-like protein mRNA 3' untranslated region (WASL mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wiskott-Aldrich syndrome-like protein mRNA 3' untranslated region (WASL mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call